JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online healthcare services, online consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services; health management and intelligent healthcare solutions, as well as technical and advertising services. In addition, it offers access to medical checkups, medical aesthetics, vaccination appointments, dental care services, and nucleic acid testing tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Revenue of JD Health International Inc. (6618.HK)
Revenue in 2023 (TTM): $6.88 B
According to JD Health International Inc.'s latest financial reports the company's current revenue (TTM) is $6.88 B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of JD Health International Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $6.88 B | $1.52 B | $376.52 M | $346.08 M | $275.21 M |
| 2022 | $6.01 B | $1.27 B | $-7,829,226 | $89.41 M | $48.84 M |
| 2021 | $3.94 B | $924.8 M | $-176,245,663 | $-115,835,561 | $-137,938,466 |
| 2020 | $2.49 B | $631.84 M | $46.84 M | $-2,193,655,884 | $-2,214,500,325 |
| 2019 | $1.39 B | $361.36 M | $56.14 M | $-107,253,365 | $-124,870,440 |
| 2018 | $1.05 B | $254.28 M | $40.17 M | $39.35 M | $27.62 M |
| 2017 | $713.54 M | $177.38 M | $33.3 M | $32.89 M | $22.94 M |